Pharmaceutical Intermediates
High Quality Chemical Pharmaceutical Intermediate Baloxavir Marboxil CAS No. 1985606Overview We provide DOOR-TO-DOOR shipping, including customs clearance. 1: Fast and guaranteed shipment (TNT;EMS;FEDEX;D
High Quality Weight Loss Material USP40 LProduct Description L-Carnitine is a naturally occurring amino acid derivative that is crucial for energy production in
Pharmaceutical Intermediates NFOverview Factory Best Selling CAS 1672-88-4 Furazidine Powder with Best Price Furagin, nitrofurantoin analog, is an anti
Pharmaceutical Intermediate Best Quality 99% Powder Lurasidone IntermediateOverview Packing Pictures Our exhibition: We are looking forward to your inquiry Jinan Jianfeng Chemical Co., Ltd CAS 36
Yinherb Supply Pharmaceutical Intermediate NYinherb N-Acetyl-Epithalon Peptide Bulk powder Product: Epithalon CAS: 307297-39-8 MF: C14H22N4O9 Sequence: alanyl-gluta
High Quality and Good Price for Pharmaceutical Upadacitinib Intermediates 1869118High Quality and Good Price for Pharmaceutical Upadacitinib Intermediates 1869118
Shanghai Pemichem Lab Supply Raw Materials Pharmaceutical Intermediates Powder Msa1.For some materials, we could supply free Samples for testing at first..2.MOQ: 1g or 5g3.More than 3000 kinds of materi
Pharmaceutical Intermediate Etravirine /Tmc125 CAS 269055Pharmaceutical Intermediate Etravirine /Tmc125 CAS 269055-15-4 Specification of Analysis Etravirine is a second-generati
99% High Purity Pharmaceutical Intermediate 6Item name: 6-APA Other names: 6-Aminopenicillanic acid/6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-ca
Factory Wholesale Price Chinese Supplier Pharmaceutical Intermediate CAS. 20168Overview This strain is a derivative of indole aryl acetic acid, which is a non-steroidal anti-inflammatory, analgesic a
Factory Directly Sales Best Price Pharmaceutical Organic Intermediate CAS 109Private Label OEM Capsules with Jar 1. Customized formulas and packaging. 2. High-quality labels and materials. 3. Vario
High Quality CAS 1195765Overview Dabrafenib is a targeted therapy used to treat cancer patients with a mutation in the BRAF V600E or BRAF V600K












